Case Study: Labcorp Patient Mark gains peace of mind through prostate cancer screening and genetic testing with Labcorp

Labcorp Patient (Mark) gains peace of mind with LabCorp’s 32% prostate cancer risk insight

The customer, a Labcorp patient named Mark, faced the challenge of monitoring a slow but steady rise in his PSA levels, which indicated a potential risk for prostate cancer. He and his care team needed a way to proactively manage his health and make informed decisions without immediately resorting to invasive treatment. Labcorp provided the crucial PSA screening service that enabled his long-term active surveillance.

Labcorp's PSA testing provided the consistent data Mark and his physicians required to monitor his health over several years. When a biopsy confirmed prostate cancer, additional testing from Labcorp offered further insight into the cancer's aggressiveness, estimating a 32% chance it could become more serious. This information was critical in guiding the decision to eventually proceed with successful surgery. The solution resulted in a positive health outcome for Mark and also prompted his brother to get screened, leading to an early diagnosis and successful treatment for him as well.

Labcorp Patient (Mark)